Neuphoria Therapeutics Inc. (NEUP)
NASDAQ: NEUP · Real-Time Price · USD
5.19
+0.07 (1.37%)
At close: Apr 29, 2026, 4:00 PM EDT
5.29
+0.10 (1.93%)
After-hours: Apr 29, 2026, 5:33 PM EDT
Neuphoria Therapeutics Market Cap
Neuphoria Therapeutics has a market cap or net worth of $27.98 million as of April 29, 2026. Its market cap has increased by 208.16% in one year.
Market Cap
27.98M
Enterprise Value
5.84M
1-Year Change
208.16%
Ranking
Category
Stock Price
$5.19
Market Cap Chart
Since December 24, 2024, Neuphoria Therapeutics's market cap has increased from $10.79M to $27.98M, an increase of 159.33%. That is a compound annual growth rate of 103.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 29, 2026 | 27.98M | 34.10% |
| Dec 31, 2025 | 20.86M | 273.80% |
| Dec 31, 2024 | 5.58M | -48.27% |
| Dec 24, 2024 | 10.79M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BriaCell Therapeutics | 29.18M |
| Lisata Therapeutics | 28.99M |
| Outlook Therapeutics | 28.77M |
| Kyntra Bio | 28.53M |
| Tevogen Bio Holdings | 27.67M |
| Apollomics | 27.59M |
| NeuroSense Therapeutics | 27.50M |
| NanoViricides | 27.21M |